Drug Type Antibody |
Synonyms |
Target- |
Action- |
Mechanism- |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic Kidney Diseases | Preclinical | Singapore | 28 Aug 2024 | |
Rheumatoid Arthritis | Preclinical | Singapore | 28 Aug 2024 |